Skip to content

A study to investigate appetite in older adults residing in nursing homes.

An exploratory study investigating the effect of adding an appetite stimulant to an ONS on appetite-related outcomes in older adults residing in nursing homes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22468
Enrollment
45
Registered
2021-07-15
Start date
2021-09-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Duration of intervention: 2 weeks Intervention group: One bottle of ONS (125 mL), mixed with an appetite stimulant dissolved in 5 mL of water Control group: One bottle of ONS (125 mL) mixed with 5 mL

Sponsors

Danone Nutricia Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 65 years of age or older 2. Residing in a nursing home 3. Able to consume high energy and/or high protein ONS at discretion of the Investigator 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Any known gastrointestinal (GI) disease that interferes with the gastrointestinal motility and nutritional intake, e.g. constipation or diarrhoea secondary to neuropathy, diarrhoea due to chronic inflammatory bowel disease, gastroparesis 2. Any known metabolic condition that interferes with the breakdown of amino acids 3. History of GI surgery (except appendectomy) that interferes with the GI function, e.g. ileostomy, colostomy, (partial) gastrectomy or any other procedure for stomach volume reduction, including gastric banding 4. Investigator’s uncertainty about the willingness or ability of the subject to comply with the protocol requirements, for example due to the presence of a psychiatric disorder (e.g. major depression, psychoses), dementia or Alzheimer’s disease 5. Known allergy to cow’s milk protein 6. Known galactosaemia 7. Known severe lactose intolerance without using lactase 8. Enrolment in any other studies involving investigational or marketed products concomitantly or within two weeks prior to baseline

Design outcomes

Primary

MeasureTime frame
The main outcome parameter in this study is the composite satiety score (CSS), measured from baseline until 120 minutes after starting the consumption of the study product: -Area under the curve (AUC; score x minutes) -Incremental area under the curve (iAUC; score x minutes) -Absolute values (score) at baseline (-5 minutes) and 15, 30, 45, 60, 90 and 120 minutes after starting the consumption of the study product -Change from baseline (score) at 15, 30, 45, 60, 90 and 120 minutes after starting the consumption of the study product The CSS will be calculated through the equation (satiety + fullness + (100 – hunger) + (100 – prospective food consumption))/ 4. Satiety, fullness, hunger and prospective food consumption will be assessed on a VAS, with scores ranging from 0 to 100. The CSS also ranges from 0 to 100.

Secondary

MeasureTime frame
Other outcome parameters in this study are: -Satiety, fullness, hunger, prospective food consumption measured from baseline until 120 minutes after starting the consumption of the study product - AUC (score x minutes) - iAUC (score x minutes) - Absolute values (score) at baseline (-5 minutes) and 15, 30, 45, 60, 90 and 120 minutes after starting the consumption of the study product - Change from baseline (score) at 15, 30, 45, 60, 90 and 120 minutes after starting the consumption of the study product -Adherence to use of the study product, defined as volume consumed within 15 minutes relative to 1 serving (%) -Overall liking of the study product (score), assessed 15 minutes after starting the consumption of the study product on a liking scale ranging from 1 to 10.

Contacts

Public ContactDanone Nutricia Research

Danone Nutricia Research

register.clinicalresearchnutricia@danone.com+31 30 2095 000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)